IBS of America
USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: D21F (Paper-making MACHINES; Methods OF Producing Paper Thereon).
The verdict
According to USPTO PatentsView, IBS ranks #16,873 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 3 technology areas.
- #16,873
- of 49,997 US assignees by volume
- Top 40%
- by Innovation Score (38.6/100)
- 19.0
- avg claims per patent
- -30%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R16873 · US Corporation #16,873 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 17 grants
- MID-PACK #16,873/49,997
- PHOTO-FINISH Hydrostor
- CPC-NARROW D21F · 3 areas
- INNOV-THIN 38.6/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -30% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Hydrostor Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How IBS’s 38.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around IBS
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- IBS of America · this assignee
IBS of America · this assignee
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows IBS's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for IBS?
Each dot is one of IBS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). IBS’s own 19.0 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where IBS's grants concentrate
IBS of America is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under D21F (Paper-making MACHINES; Methods OF Producing Paper Thereon). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2018. By volume, IBS sits between HyTrust, Inc. and IMS Health Incorporated.
IBS's three-year grant acceleration
IBS of America shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at IBS's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hytrust
HyTrust, Inc.
17 patents
- Hydrostor
Hydrostor Inc.
17 patents
- Hygieia
Hygieia, Inc.
17 patents
- I-pex
I-pex Inc.
17 patents
- Ildong Pharmaceut…
Ildong Pharmaceutical Co., Ltd.
17 patents
- Image Match Design
Image Match Design Inc.
17 patents
- Immunomet Therape…
Immunomet Therapeutics Inc.
17 patents
- IMS Health Incorp…
IMS Health Incorporated
17 patents
- IBS of America ◀
IBS of America
17 patents
What this shows IBS holds 17 patents at rank #16,873, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near IBS
By rank, the assignees closest to #16,873 in granted patent volume.
- HyTrust, Inc. #16,869 · 17 patents
- Hydrostor Inc. #16,870 · 17 patents
- Hygieia, Inc. #16,871 · 17 patents
- I-pex Inc. #16,872 · 17 patents
- Ildong Pharmaceutical Co., Ltd. #16,874 · 17 patents
- Image Match Design Inc. #16,875 · 17 patents
- Immunomet Therapeutics Inc. #16,876 · 17 patents
- IMS Health Incorporated #16,877 · 17 patents
Leaders in D21F (Paper-making Machines)
Other assignees with the most granted patents in IBS's primary technology class.
IBS's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 17.6% |
| 2016 | 2 | 11.8% |
| 2017 | 3 | 17.6% |
| 2018 | 1 | 5.9% |
| 2019 | 1 | 5.9% |
| 2021 | 2 | 11.8% |
| 2022 | 1 | 5.9% |
| 2023 | 3 | 17.6% |
| 2024 | 1 | 5.9% |
Which technologies does IBS of America patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
IBS of America's patent record in context - here's where to go next.
- IBS of America's lead technology class is D21F (Paper-making MACHINES; Methods OF Producing Paper Thereon), 100% of its portfolio - see every assignee active in that class. Explore D21F
- Ranked #16,873 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare IBS of America against HyTrust, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.